HBM Healthcare Investments expects half-year profit of CHF 177 million; NAV per share rises 9.8% to CHF 297.30 in first half of FY26/27

Bitget2026/10/01 15:49

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

HBM Healthcare Investments expects profit of about CHF 177 million for the first half of FY 2026/2027.
NAV per share rose 9.8% to CHF 297.30, adjusted for a CHF 9.00 dividend.
Dividend-adjusted share price climbed 7.8% to CHF 233.50, leaving it about 21% below NAV.
Private companies contributed CHF 138 million, including a CHF 74 million uplift from Dren Bio and CHF 32 million from Curevo Vaccine’s sale.
Listed holdings added CHF 107 million; NAV fell 2.9% in the second quarter after a strong first quarter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HBM Healthcare Investments AG published the original content used to generate this news brief via EQS News (Ref. ID: adhoc_2409176_en) on October 01, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

HBM Healthcare Investments expects half-year profit of CHF 177 million; NAV per share rises 9.8% to CHF 297.30 in first half of FY26/27

You may also like

Crypto prices